HilleVax

Boston, United States

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

Sep 2023

Post-IPO Equity

Top Investors

Lightspeed Venture PartnersRA Capital ManagementSamsara BioCapitalPerceptive AdvisorsAbingworth

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are HilleVax's investors?

HilleVax's investors include Lightspeed Venture Partners, RA Capital Management, Samsara BioCapital, Perceptive Advisors, Abingworth.

Where is HilleVax headquartered?

HilleVax is headquartered in Boston, United States.

What does HilleVax do?

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

What stage is HilleVax at?

HilleVax is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 19, 2023.

MLA

"HilleVax — Funding & Investors." VCBacked, September 19, 2023, https://www.vcbacked.co/company/hillevax. Accessed July 1, 2026.

APA

VCBacked. (2023). HilleVax — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/hillevax

Wikipedia (cite web)

{{cite web |title=HilleVax — Funding & Investors |url=https://www.vcbacked.co/company/hillevax |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 19, 2023.